Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease (ESRD) and is therefore a major burden on the healthcare system. Patients with DKD are highly susceptible to developing cardiovascular disease, which contributes to increased morbidity and mortality rates. While progr...
Main Authors: | Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Daiji Kawanami, Kazunori Utsunomiya, Rimei Nishimura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/14/3393 |
Similar Items
-
Renal ROCK Activation and Its Pharmacological Inhibition in Patients With Diabetes
by: Keiichiro Matoba, et al.
Published: (2021-09-01) -
Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease
by: Keiichiro Matoba, et al.
Published: (2020-02-01) -
The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease
by: Keiichiro Matoba, et al.
Published: (2020-09-01) -
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
by: Daiji Kawanami, et al.
Published: (2017-05-01) -
Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy
by: Keiichiro Matoba, et al.
Published: (2017-08-01)